ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) traded up 6.8% on Tuesday following a better than expected earnings announcement. The stock traded as high as $3.01 and last traded at $3.05.

New Fortress Energy Inc. (NASDAQ:NFE – Get Free Report)’s share price was up 8% on Tuesday after the company announced better than expected quarterly earnings. The company traded as high as $9.66 and ...

We recently published an article titled Trade Tensions Weigh Heavily on 10 Stocks. In this article, we are going to take a ...

Full Year 2024 Results Key Financial Results Revenue: US$14.7m (up by US$14.1m from ...

Immunitybio Inc ( ($IBRX) ) has released its Q4 earnings. Here is a breakdown of the information Immunitybio Inc presented to its investors.

ImmunityBio’s revenue growth was driven by sales of its ANKTIVA therapy following FDA approval in April 2024. The company reported net product revenue of $7.2 million for Q4, representing a 21% ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following approval of the permanent J-c ...

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for Anktiva ...

D. Boral Capital reaffirmed their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a research report released on Friday,Benzinga reports. The firm currently has a $30.00 target price ...

StockNews.com lowered shares of GoPro (NASDAQ:GPRO – Free Report) from a hold rating to a sell rating in a research report released on Friday. Separately, Wedbush reiterated a “neutral” rating and ...

GitLab (NASDAQ:GTLB – Free Report) had its price objective cut by DA Davidson from $70.00 to $60.00 in a report published on Friday morning,Benzinga reports. They currently have a neutral rating on ...

We recently compiled a list of the Wall Street Optimism Spills Over to These 10 Stocks on Friday. In this article, we are ...